The VEGF receptor tyrosine kinase inhibitor, ZD6474, inhibits angiogenesis and affects microvascular architecture within an orthotopically implanted renal cell carcinoma

Author： Drevs J.  

Publisher： Springer Publishing Company

ISSN： 0969-6970

Source： Angiogenesis, Vol.7, Iss.4, 2004-12, pp. : 347-354

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The small molecule specific EphB4 kinase inhibitor NVP-BHG712 inhibits VEGF driven angiogenesis

By Martiny-Baron Georg  

Angiogenesis, Vol. 13, Iss. 3, 2010-09 ,pp. : 259-267

Springer Publishing Company

Access to resources Recommend Favorite

Inhibition of Vascular Endothelial Growth Factor-Associated Tyrosine Kinase Activity with SU5416 Blocks Sprouting in the Microvascular Endothelial Cell Spheroid Model of Angiogenesis

By Haspel H.C.   Scicli G.M.   McMahon G.   Scicli A.G.  

Microvascular Research, Vol. 63, Iss. 3, 2002-05 ,pp. : 304-315

Academic Press

Access to resources Recommend Favorite

Present and Future of Tyrosine Kinase Inhibitors in Renal Cell Carcinoma: Analysis of Hematologic Toxicity

By  

Recent Patents on Anti-Infective Drug Discovery, Vol. 7, Iss. 2, 2012-08 ,pp. : 104-110

Bentham Science Publishers

Access to resources Recommend Favorite

Binding and displacement of vascular endothelial growth factor (VEGF) by thrombospondin: Effect on human microvascular endothelial cell proliferation and angiogenesis

By Gupta K.  

Angiogenesis, Vol. 3, Iss. 2, 1999-01 ,pp. : 147-158

Springer Publishing Company

Access to resources Recommend Favorite

TIE1 and TIE2 Receptor Tyrosine Kinases Inversely Regulate Embryonic Angiogenesis by the Mechanism of Intussusceptive Microvascular Growth

By Patan S.  

Microvascular Research, Vol. 56, Iss. 1, 1998-07 ,pp. : 1-21

Academic Press

Access to resources Recommend Favorite